Twitter Facebook LinkedIn YouTube

M Pharmaceutical (CSE: MQ) rebrands itself under the mantra “Better Health. Better Life.”

Video Platform Video Management Video Solutions Video Player

M Pharmaceutical, symbol MQ on the Canadian Securities Exchange, (OTCQB:MPHMF) (FSE:T3F1) has rebranded itself under the mantra “Better Health. Better Life.” The company is committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes. The rebranding is designed to provide greater understanding of the company’s emerging family of biomedical technologies, which are linked by the common "M" embedded in a stylized Circle of Life.

Additional Information:

Company: M Pharmaceutical
Website: http://m-pharma.ca/
Stock Symbol: CSE: MQ
Date Published: Jul 16, 2015
Transcript: Available

Video Transcript:

M Pharmaceutical (CSE: MQ) rebrands itself under the mantra “Better Health. Better Life.”


I’m Samantha Deutscher for Investmentpitch Media

M Pharmaceutical, symbol MQ on the Canadian Securities Exchange, (OTCQB:MPHMF) (FSE:T3F1) has rebranded itself under the mantra “Better Health. Better Life.”

The company is committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes.

The rebranding is designed to provide greater understanding of the company’s emerging family of biomedical technologies, which are linked by the common "M" embedded in a stylized Circle of Life.

The corporate brand mark and all product marks will share the common M in a colour-coded protocol that will be consistently applied across all communications platforms.

Joining the eMosquito Wearable Blood Monitor will be Trimeo Weight Loss Capsules and the Trimtec Gastric Stimulation System.

Dr. Martin Mintchev, President & CEO stated: "Our new approach and communications platform will help us in our pursuit of excellence in the biomedical technologies that we believe will make a palpable difference in the lives of people living with obesity and diabetes. The rebranding simplifies the comprehensive vision of M Pharmaceutical, Inc. and crystalizes the story behind the eMosquito. In introducing Trimeo and Trimtec to our family, it represents an exciting new chapter in the growth and development of our company."

The company is currently undertaking a non-brokered private placement of up to $350,000, through the issuance of up to 3,888,888 units at $0.09 per unit, which is the current share price in the market.

Each unit consists of one common share and one share purchase warrant exercisable for one year at $0.25.

On June 24th, New York based SeeThruEquity initiated coverage on M Pharmaceutical. Analyst Amit Tandon gave M-Pharma a target price of $0.79, a premium of 316% to the $0.19 price the day the report was issued.

George Tsafalas, a member of the Board of Directors added: "Based on the quality of people who have joined with Dr. Mintchev on our leadership team, our Board and our Advisory group, and given the progress the team has made on all fronts, we believed it was the right time to usher in our new look and feel."

For more information about M-Pharma, please visit the company’s website www.m-pharma.ca, call 604-428-0511 or email info@m-pharma.ca.

I’m Samantha Deutscher for Investmentpitch Media
For more video news, and to view our disclaimer, please visit our website at www.investmentpitch.com
This video is for information purposes only and it not a recommendation to buy or sell any securities.